Amica Retiree Medical Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $598K | Hold |
2,583
| – | – | 0.82% | 39 |
|
|
2025
Q2 | $479K | Hold |
2,583
| – | – | 0.69% | 44 |
|
|
2025
Q1 | $541K | Sell |
2,583
-617
| -19% | -$120K | 0.83% | 36 |
|
|
2024
Q4 | $569K | Sell |
3,200
-277
| -8% | -$50.9K | 0.54% | 51 |
|
|
2024
Q3 | $687K | Buy |
+3,477
| New | +$649K | 0.57% | 45 |
|
|
2023
Q3 | $349K | Hold |
2,340
| – | – | 0.41% | 76 |
|
|
2023
Q2 | $315K | Sell |
2,340
-1,207
| -34% | -$177K | 0.35% | 82 |
|
|
2023
Q1 | $565K | Sell |
3,547
-1,238
| -26% | -$189K | 0.6% | 57 |
|
|
2022
Q4 | $773K | Sell |
4,785
-1,024
| -18% | -$157K | 0.99% | 36 |
|
|
2022
Q3 | $780K | Buy |
5,809
+1,127
| +24% | +$162K | 0.98% | 35 |
|
|
2022
Q2 | $717K | Buy |
4,682
+607
| +15% | +$92.8K | 0.81% | 45 |
|
|
2022
Q1 | $661K | Sell |
4,075
-2,958
| -42% | -$430K | 0.62% | 59 |
|
|
2021
Q4 | $952K | Hold |
7,033
| – | – | 0.81% | 38 |
|
|
2021
Q3 | $759K | Buy |
7,033
+518
| +8% | +$59.2K | 0.69% | 50 |
|
|
2021
Q2 | $734K | Hold |
6,515
| – | – | 0.46% | 73 |
|
|
2021
Q1 | $705K | Hold |
6,515
| – | – | 0.48% | 73 |
|
|
2020
Q4 | $698K | Hold |
6,515
| – | – | 0.49% | 69 |
|
|
2020
Q3 | $571K | Hold |
6,515
| – | – | 0.44% | 79 |
|
|
2020
Q2 | $640K | Hold |
6,515
| – | – | 0.51% | 56 |
|
|
2020
Q1 | $496K | Hold |
6,515
| – | – | 0.44% | 58 |
|
|
2019
Q4 | $577K | Hold |
6,515
| – | – | 0.45% | 55 |
|
|
2019
Q3 | $493K | Hold |
6,515
| – | – | 0.39% | 70 |
|
|
2019
Q2 | $474K | Hold |
6,515
| – | – | 0.39% | 76 |
|
|
2019
Q1 | $525K | Sell |
6,515
-957
| -13% | -$78.3K | 0.46% | 57 |
|
|
2018
Q4 | $689K | Hold |
7,472
| – | – | 0.66% | 37 |
|
|
2018
Q3 | $707K | Hold |
7,472
| – | – | 0.59% | 42 |
|
|
2018
Q2 | $692K | Sell |
7,472
-2,168
| -22% | -$212K | 0.6% | 37 |
|
|
2018
Q1 | $912K | Hold |
9,640
| – | – | 0.8% | 22 |
|
|
2017
Q4 | $932K | Hold |
9,640
| – | – | 0.7% | 31 |
|
|
2017
Q3 | $857K | Hold |
9,640
| – | – | 0.68% | 29 |
|
|
2017
Q2 | $699K | Hold |
9,640
| – | – | 0.57% | 39 |
|
|
2017
Q1 | $628K | Hold |
9,640
| – | – | 0.51% | 47 |
|
|
2016
Q4 | $604K | Hold |
9,640
| – | – | 0.48% | 49 |
|
|
2016
Q3 | $608K | Hold |
9,640
| – | – | 0.51% | 48 |
|
|
2016
Q2 | $597K | Sell |
9,640
-474
| -5% | -$28.9K | 0.51% | 48 |
|
|
2016
Q1 | $578K | Hold |
10,114
| – | – | 0.49% | 56 |
|
|
2015
Q4 | $599K | Hold |
10,114
| – | – | 0.52% | 51 |
|
|
2015
Q3 | $550K | Hold |
10,114
| – | – | 0.5% | 58 |
|
|
2015
Q2 | $680K | Hold |
10,114
| – | – | 0.58% | 46 |
|
|
2015
Q1 | $592K | Hold |
10,114
| – | – | 0.5% | 60 |
|
|
2014
Q4 | $662K | Hold |
10,114
| – | – | 0.54% | 51 |
|
|
2014
Q3 | $584K | Hold |
10,114
| – | – | 0.49% | 56 |
|
|
2014
Q2 | $571K | Sell |
10,114
-1,472
| -13% | -$77.2K | 0.47% | 58 |
|
|
2014
Q1 | $596K | Hold |
11,586
| – | – | 0.51% | 51 |
|
|
2013
Q4 | $612K | Buy |
+11,586
| New | +$569K | 0.53% | 52 |
|
Other funds holding ABBV
Amica Retiree Medical Trust's ABBV Position: Q3 2025 in Review
Amica Retiree Medical Trust held its AbbVie (ABBV) position steady in Q3 2025 at 2,583 shares worth $598K. The position accounts for 0.82% of the portfolio, ranked #39.
Amica Retiree Medical Trust first reported a position in ABBV in Q4 2013 and has held it in 45 quarters since. The position peaked at $952K in Q4 2021. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Amica Retiree Medical Trust held 2,583 shares of AbbVie worth $598K as of Q3 2025.
- Amica Retiree Medical Trust left its AbbVie share count unchanged in Q3 2025.
- AbbVie made up 0.82% of Amica Retiree Medical Trust's portfolio in Q3 2025, its #39 holding.
- Amica Retiree Medical Trust first reported a position in AbbVie in Q4 2013 and has held it in 45 quarters since.
- Amica Retiree Medical Trust's AbbVie position peaked at $952K in Q4 2021.
- 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Amica Retiree Medical Trust's 13F filing for Q3 2025, filed 7 Nov 2025.